- Home
- CRVS vs MNRO Comparison
CRVS vs MNRO Comparison
Compare CRVS & MNRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CRVS | MNRO |
|---|---|---|
| Founded | 2014 | 1957 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Automotive Aftermarket |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 634.0M | 635.2M |
| IPO Year | 2016 | 1991 |
Fundamental Metrics
Financial Performance| Metric | CRVS | MNRO |
|---|---|---|
| Price | $7.69 | $20.02 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $13.75 | ★ $17.67 |
| AVG Volume (30 Days) | ★ 1.6M | 735.7K |
| Earning Date | 11-04-2025 | 01-28-2026 |
| Dividend Yield | N/A | ★ 5.59% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,190,710,000.00 |
| Revenue This Year | N/A | $0.14 |
| Revenue Next Year | N/A | $2.67 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.54 | $12.20 |
| 52 Week High | $9.60 | $25.14 |
Technical Indicators
Market Signals| Indicator | CRVS | MNRO |
|---|---|---|
| Relative Strength Index (RSI) | 45.27 | 51.65 |
| Support Level | $7.28 | $20.19 |
| Resistance Level | $7.86 | $20.81 |
| Average True Range (ATR) | 0.42 | 0.54 |
| MACD | -0.07 | -0.17 |
| Stochastic Oscillator | 29.01 | 8.45 |
Price Performance
Historical ComparisonAbout CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About MNRO Monro Inc.
Monro Inc is an operator of retail tire and automotive repair stores in the United States. The company offers replacement tires and tire related services, automotive undercar repair services, and a broad range of routine maintenance services, on passenger cars, light trucks, and vans. It also provides other products and services for brakes; mufflers and exhaust systems; and steering, drive train, suspension, and wheel alignment.